Spectrum Pharmaceutecals Inc (SPPI)

[Tartiaboy]

IF you will indulge me. Now that I am mostly cash perhaps I am more critical.

Let's accept that SPPI has about $350M in cash and equity, with no clear revenue stream (a licensing deal or sale of Qap are speculative).

My estimate is that SPPI will burn about $200M per year. I have never seen SPPI allow cash to go below $100M.

So SPPI has about 5 or 6 quarters before they need new revenue, unless they sell or license something that may buy another quarter or so.

If Rolontis hits the ground running in 2020, all will be well, but if sales don't ramp up quickly to the $200M+ range, there will be problems.

Where is this wrong?